← Evidence map

TrialInflammopharmacology2025

Repurposing of high-dose N-acetylcysteine as anti-inflammatory, antioxidant and neuroprotective  agent  in moderate to severe traumatic brain injury patients: a randomized controlled trial.

Alaa Refaat Gouda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 40205270